{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699995734150528.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1161/circoutcomes.109.930735"}},{"identifier":{"@type":"URI","@value":"https://www.ahajournals.org/doi/full/10.1161/CIRCOUTCOMES.109.930735"}}],"dc:title":[{"@value":"Vascular Hospitalization Rates and Costs in Patients With Peripheral Artery Disease in the United States"}],"description":[{"type":"abstract","notation":[{"@value":"<jats:sec>\n            <jats:title>Background—</jats:title>\n            <jats:p>\n              Peripheral artery disease (PAD) is common and imposes a high risk of major systemic and limb ischemic events. The\n              <jats:italic>RE</jats:italic>\n              duction of\n              <jats:italic>A</jats:italic>\n              therothrombosis for\n              <jats:italic>C</jats:italic>\n              ontinued\n              <jats:italic>H</jats:italic>\n              ealth (REACH) Registry is an international prospective registry of patients at risk of atherothrombosis caused by established arterial disease or the presence of ≥3 atherothrombotic risk factors.\n            </jats:p>\n          </jats:sec>\n          <jats:sec>\n            <jats:title>Methods and Results—</jats:title>\n            <jats:p>\n              We compared the 2-year rates of vascular-related hospitalizations and associated costs in US patients with established PAD across patient subgroups. Symptomatic PAD at enrollment was identified on the basis of current intermittent claudication with an ankle-brachial index (ABI) <0.90 or a history of lower-limb revascularization or amputation. Asymptomatic PAD was diagnosed on the basis of an enrollment ABI <0.90 in the absence of symptoms. Overall, 25 763 of the total 68 236–patient REACH cohort were enrolled from US sites; 2396 (9.3%) had symptomatic and 213 (0.8%) had asymptomatic PAD at baseline. One- and cumulative 2-year follow-up data were available for 2137 (82%) and 1677 (64%) of US REACH patients with either symptomatic or asymptomatic PAD, respectively. At 2 years, mean cumulative hospitalization costs, per patient, were $7445, $7000, $10 430, and $11 693 for patients with asymptomatic PAD, a history of claudication, lower-limb amputation, and revascularization, respectively (\n              <jats:italic>P</jats:italic>\n              =0.007). A history of peripheral intervention (lower-limb revascularization or amputation) was associated with higher rates of subsequent procedures at both 1 and 2 years.\n            </jats:p>\n          </jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions—</jats:title>\n            <jats:p>The economic burden of PAD is high. Recurring hospitalizations and repeat revascularization procedures suggest that neither patients, physicians, nor healthcare systems should assume that a first admission for a lower-extremity PAD procedure serves as a permanent resolution of this costly and debilitating condition.</jats:p>\n          </jats:sec>"}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699995734150532","@type":"Researcher","foaf:name":[{"@value":"Elizabeth M. Mahoney"}],"jpcoar:affiliationName":[{"@value":"From Saint Luke's Mid America Heart and Vascular Institute (E.M.M., K.W., K.S., D.J.C.), Kansas City, Mo; University of Missouri–-Kansas City School of Medicine (E.M.M., D.J.C.), Kansas City, Mo; the Center of Research on Psychology and Somatic Diseases (K.S.), Tilburg University, Tilburg, The Netherlands; the Division of Epidemiology and Community Health (H.H.K., S.D., A.T.H.), University of Minnesota School of Public Health, Minneapolis, Minn; INSERM U-698 (P.G.S.), Université Paris 7 and..."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995734150531","@type":"Researcher","foaf:name":[{"@value":"Kaijun Wang"}],"jpcoar:affiliationName":[{"@value":"From Saint Luke's Mid America Heart and Vascular Institute (E.M.M., K.W., K.S., D.J.C.), Kansas City, Mo; University of Missouri–-Kansas City School of Medicine (E.M.M., D.J.C.), Kansas City, Mo; the Center of Research on Psychology and Somatic Diseases (K.S.), Tilburg University, Tilburg, The Netherlands; the Division of Epidemiology and Community Health (H.H.K., S.D., A.T.H.), University of Minnesota School of Public Health, Minneapolis, Minn; INSERM U-698 (P.G.S.), Université Paris 7 and..."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995734150528","@type":"Researcher","foaf:name":[{"@value":"Hong H. Keo"}],"jpcoar:affiliationName":[{"@value":"From Saint Luke's Mid America Heart and Vascular Institute (E.M.M., K.W., K.S., D.J.C.), Kansas City, Mo; University of Missouri–-Kansas City School of Medicine (E.M.M., D.J.C.), Kansas City, Mo; the Center of Research on Psychology and Somatic Diseases (K.S.), Tilburg University, Tilburg, The Netherlands; the Division of Epidemiology and Community Health (H.H.K., S.D., A.T.H.), University of Minnesota School of Public Health, Minneapolis, Minn; INSERM U-698 (P.G.S.), Université Paris 7 and..."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995734150533","@type":"Researcher","foaf:name":[{"@value":"Sue Duval"}],"jpcoar:affiliationName":[{"@value":"From Saint Luke's Mid America Heart and Vascular Institute (E.M.M., K.W., K.S., D.J.C.), Kansas City, Mo; University of Missouri–-Kansas City School of Medicine (E.M.M., D.J.C.), Kansas City, Mo; the Center of Research on Psychology and Somatic Diseases (K.S.), Tilburg University, Tilburg, The Netherlands; the Division of Epidemiology and Community Health (H.H.K., S.D., A.T.H.), University of Minnesota School of Public Health, Minneapolis, Minn; INSERM U-698 (P.G.S.), Université Paris 7 and..."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995734150536","@type":"Researcher","foaf:name":[{"@value":"Kim G. Smolderen"}],"jpcoar:affiliationName":[{"@value":"From Saint Luke's Mid America Heart and Vascular Institute (E.M.M., K.W., K.S., D.J.C.), Kansas City, Mo; University of Missouri–-Kansas City School of Medicine (E.M.M., D.J.C.), Kansas City, Mo; the Center of Research on Psychology and Somatic Diseases (K.S.), Tilburg University, Tilburg, The Netherlands; the Division of Epidemiology and Community Health (H.H.K., S.D., A.T.H.), University of Minnesota School of Public Health, Minneapolis, Minn; INSERM U-698 (P.G.S.), Université Paris 7 and..."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995734150529","@type":"Researcher","foaf:name":[{"@value":"David J. Cohen"}],"jpcoar:affiliationName":[{"@value":"From Saint Luke's Mid America Heart and Vascular Institute (E.M.M., K.W., K.S., D.J.C.), Kansas City, Mo; University of Missouri–-Kansas City School of Medicine (E.M.M., D.J.C.), Kansas City, Mo; the Center of Research on Psychology and Somatic Diseases (K.S.), Tilburg University, Tilburg, The Netherlands; the Division of Epidemiology and Community Health (H.H.K., S.D., A.T.H.), University of Minnesota School of Public Health, Minneapolis, Minn; INSERM U-698 (P.G.S.), Université Paris 7 and..."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995734150534","@type":"Researcher","foaf:name":[{"@value":"Gabriel Steg"}],"jpcoar:affiliationName":[{"@value":"From Saint Luke's Mid America Heart and Vascular Institute (E.M.M., K.W., K.S., D.J.C.), Kansas City, Mo; University of Missouri–-Kansas City School of Medicine (E.M.M., D.J.C.), Kansas City, Mo; the Center of Research on Psychology and Somatic Diseases (K.S.), Tilburg University, Tilburg, The Netherlands; the Division of Epidemiology and Community Health (H.H.K., S.D., A.T.H.), University of Minnesota School of Public Health, Minneapolis, Minn; INSERM U-698 (P.G.S.), Université Paris 7 and..."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995734150530","@type":"Researcher","foaf:name":[{"@value":"Deepak L. Bhatt"}],"jpcoar:affiliationName":[{"@value":"From Saint Luke's Mid America Heart and Vascular Institute (E.M.M., K.W., K.S., D.J.C.), Kansas City, Mo; University of Missouri–-Kansas City School of Medicine (E.M.M., D.J.C.), Kansas City, Mo; the Center of Research on Psychology and Somatic Diseases (K.S.), Tilburg University, Tilburg, The Netherlands; the Division of Epidemiology and Community Health (H.H.K., S.D., A.T.H.), University of Minnesota School of Public Health, Minneapolis, Minn; INSERM U-698 (P.G.S.), Université Paris 7 and..."}]},{"@id":"https://cir.nii.ac.jp/crid/1381699995734150535","@type":"Researcher","foaf:name":[{"@value":"Alan T. Hirsch"}],"jpcoar:affiliationName":[{"@value":"From Saint Luke's Mid America Heart and Vascular Institute (E.M.M., K.W., K.S., D.J.C.), Kansas City, Mo; University of Missouri–-Kansas City School of Medicine (E.M.M., D.J.C.), Kansas City, Mo; the Center of Research on Psychology and Somatic Diseases (K.S.), Tilburg University, Tilburg, The Netherlands; the Division of Epidemiology and Community Health (H.H.K., S.D., A.T.H.), University of Minnesota School of Public Health, Minneapolis, Minn; INSERM U-698 (P.G.S.), Université Paris 7 and..."}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"19417713"},{"@type":"EISSN","@value":"19417705"}],"prism:publicationName":[{"@value":"Circulation: Cardiovascular Quality and Outcomes"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"2010-11","prism:volume":"3","prism:number":"6","prism:startingPage":"642","prism:endingPage":"651"},"reviewed":"false","url":[{"@id":"https://www.ahajournals.org/doi/full/10.1161/CIRCOUTCOMES.109.930735"}],"createdAt":"2010-10-13","modifiedAt":"2024-05-13","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360865816809643008","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Rehabilitation contributes to lower readmission rates for individuals with peripheral arterial disease: A retrospective observational study"}]},{"@id":"https://cir.nii.ac.jp/crid/1390018971038810496","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Impact of Early Rehabilitation after Endovascular Treatment for Peripheral Arterial Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680250870144","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clopidogrel for Atherothrombotic Event Management in Patients with Peripheral Arterial Disease (COOPER) Study: Safety and Efficacy of Clopidogrel versus Ticlopidine in Japanese Patients"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680251547776","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"When Are Endovascular and Open Bypass Treatments Preferred for Femoropopliteal Occlusive Disease?"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1161/circoutcomes.109.930735"},{"@type":"CROSSREF","@value":"10.3400/avd.oa.12.00039_references_DOI_JXvyNJf5aSbARKTC4Bjl0Q8PmBf"},{"@type":"CROSSREF","@value":"10.2490/prm.20240021_references_DOI_JXvyNJf5aSbARKTC4Bjl0Q8PmBf"},{"@type":"CROSSREF","@value":"10.3400/avd.ra.18-00001_references_DOI_JXvyNJf5aSbARKTC4Bjl0Q8PmBf"},{"@type":"CROSSREF","@value":"10.1016/j.rehab.2023.101768_references_DOI_JXvyNJf5aSbARKTC4Bjl0Q8PmBf"}]}